Daily Coverage WOC Tokyo 2014


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

  • Bookmark
  • Share this Video

Clinical Experience with Intravitreal Aflibercept for Wet AMD

by Arshad M. Khanani, MD

As his amount of clinical experience with aflibercept increases, Arshad M. Khanani, MD, of Sierra Eye Associates, Reno, Nevada, USA, has noticed that for some patients improvements may not be sustained when treatment is given at 8 week intervals as directed by the product label. In this video, he summarizes his experience from a series of 21 patients treated with aflibercept for wet AMD with a treatment regimen of every 8 weeks.

7,030 video views since .
94,363 total series views.

Comments (1)

The statement should be, in a non-previous responders to Ranibizumab or Bevacizumab, Aflibercept may not be dosed every 8 weeks, and the mix of patients were 19 switch and 2 naive, and the naive ones had the results published in VIEW in a q8w regimen

jamiroquai20 (69 months ago)